These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21729912)

  • 1. Moving towards in-depth knowledge on the private health sector in low- and middle-income countries.
    Forsberg BC; Montagu D; Sundewall J
    Health Policy Plan; 2011 Jul; 26 Suppl 1():i1-3. PubMed ID: 21729912
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of the private sector in the provision of immunization services in low- and middle-income countries.
    Levin A; Kaddar M
    Health Policy Plan; 2011 Jul; 26 Suppl 1():i4-12. PubMed ID: 21729916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public & private health care partnerships.
    N J Med; 1998 May; 95(5):43-5. PubMed ID: 16013156
    [No Abstract]   [Full Text] [Related]  

  • 4. By 'default or design'? The expansion of the private health care sector in Madhya Pradesh, India.
    De Costa A; Johannson E
    Health Policy; 2011 Dec; 103(2-3):283-9. PubMed ID: 21782268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Make or buy" decisions in the production of health care goods and services: new insights from institutional economics and organizational theory.
    Preker AS; Harding A; Travis P
    Bull World Health Organ; 2000; 78(6):779-90. PubMed ID: 10916915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Private health care in Nigeria: walking the tightrope.
    Ogunbekun I; Ogunbekun A; Orobaton N
    Health Policy Plan; 1999 Jun; 14(2):174-81. PubMed ID: 10538720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public Private Partnership (PPP) for essential health services. An innovative approach for optimum and efficient use of public and private resources.
    Azam M
    World Hosp Health Serv; 2003; 39(1):1. PubMed ID: 12743880
    [No Abstract]   [Full Text] [Related]  

  • 8. Cuba--innovation through synergy.
    Thorsteinsdóttir H; Sáenz TW; Quach U; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC19-24. PubMed ID: 15583679
    [No Abstract]   [Full Text] [Related]  

  • 9. South Africa--blazing a trail for African biotechnology.
    Motari M; Quach U; Thorsteinsdóttir H; Martin DK; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC37-41. PubMed ID: 15583683
    [No Abstract]   [Full Text] [Related]  

  • 10. What can be done about the private health sector in low-income countries?
    Mills A; Brugha R; Hanson K; McPake B
    Bull World Health Organ; 2002; 80(4):325-30. PubMed ID: 12075370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indian biotechnology--rapidly evolving and industry led.
    Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682
    [No Abstract]   [Full Text] [Related]  

  • 12. South Korean biotechnology--a rising industrial and scientific powerhouse.
    Wong J; Quach U; Thorsteinsdóttir H; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC42-7. PubMed ID: 15583684
    [No Abstract]   [Full Text] [Related]  

  • 13. Round table. A role for public-private partnerships in controlling neglected diseases?
    Ridley RG; Lob-Levyt J; Sachs J; Johns D; Evans T; Bale HE; Quick JD; Orbinski J
    Bull World Health Organ; 2001; 79(8):771-7. PubMed ID: 11545335
    [No Abstract]   [Full Text] [Related]  

  • 14. The emergence of Egyptian biotechnology from generics.
    Abdelgafar B; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS
    Nat Biotechnol; 2004 Dec; 22 Suppl():DC25-30. PubMed ID: 15583680
    [No Abstract]   [Full Text] [Related]  

  • 15. Private sector joins family planning effort.
    Front Lines; 1989 Dec; ():6, 13. PubMed ID: 12343476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Private local pharmacies in low- and middle-income countries: a review of interventions to enhance their role in public health.
    Smith F
    Trop Med Int Health; 2009 Mar; 14(3):362-72. PubMed ID: 19207171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What can be done about the private health sector in low-income countries?
    Mills A; Brugha R; Hanson K; McPake B
    World Hosp Health Serv; 2002; 38(3):24-30, 41-4. PubMed ID: 12602088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prohibit, constrain, encourage, or purchase: how should we engage with the private health-care sector?
    Montagu D; Goodman C
    Lancet; 2016 Aug; 388(10044):613-21. PubMed ID: 27358250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting safe motherhood through the private sector in low- and middle-income countries.
    Brugha R; Pritze-Aliassime S
    Bull World Health Organ; 2003; 81(8):616-23. PubMed ID: 14576894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring opportunities for collaboration between the corporate sector and the dental education community.
    Alexander D; Clarkson J; Buchanan R; Chadwick G; Chesters R; Drisko CL; Douglass CW; Farrell L; Fletcher K; Makoni F; Monaco M; Nordquist B; Park NI; Riggs S; Schou L; Smales FC; Stamm JW; Toh CG; Volpe T; Ward P; Warren P
    Eur J Dent Educ; 2008 Feb; 12 Suppl 1():64-73. PubMed ID: 18289269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.